Unlocking Insights into Cataract Surgery and Outcomes

Cataracts affect millions of people worldwide, clouding vision and impacting quality of life. The condition occurs when the eye's natural lens becomes clouded, impairing vision. Cataracts develop gradually, leading to symptoms such as blurred vision, difficulty seeing at night, glare sensitivity, and faded colors. If left untreated, cataracts can cause severe vision loss.

The most effective treatment is cataract surgery in which the cloudy lens is removed and replaced with a synthetic intraocular lens (IOL), restoring clear vision. However, variations in surgical techniques, IOL models, and patient characteristics can impact outcomes, making real-world data essential for understanding long-term effectiveness and optimizing patient care.

Verana Health's Qdata Cataracts, a research-ready, fit-for-purpose real-world data module,  offers life sciences companies real-world insights into patient demographics, clinical outcomes, and treatment effectiveness on 9M+ cataract surgery patients. Key patient outcomes, including visual acuity (VA), IOP readings, intraocular lens (IOL) brands/models, and femtosecond laser assisted cataract surgery (FLACS)*, are extracted from unstructured and semi-structured fields in EHRs, which Verana Health has access to through an exclusive data partnership with the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight). The IRIS Registry is the world's largest specialty society clinical data registry in all of medicine and the first comprehensive eye disease clinical registry in the U.S.